Yolanda C. Nesbeth

Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity

Juan R. Cubillos‐Ruiz, Xavier Engle, Uciane K. Scarlett et al. · Journal of Clinical Investigation · 2009 · 207 citations · Full text

Immunology, Immunoediting, Immunotherapeutics +17

<i>In situ</i> Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer–Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells

Uciane K. Scarlett, Juan R. Cubillos‐Ruiz, Yolanda C. Nesbeth et al. · Cancer Research · 2009 · 131 citations · Full text

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Eduardo Huarte, Juan R. Cubillos‐Ruiz, Yolanda C. Nesbeth et al. · Cancer Research · 2008 · 114 citations · Full text

Cancer Immunosurveillance, Tumor Growth Restriction, Medicine +14

CD4+ T Cells Elicit Host Immune Responses to MHC Class II− Ovarian Cancer through CCL5 Secretion and CD40-Mediated Licensing of Dendritic Cells

Yolanda C. Nesbeth, Diana G. Martinez, Seiko Toraya et al. · The Journal of Immunology · 2010 · 77 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immune Regulation +24

CD277 is a Negative Co-stimulatory Molecule Universally Expressed by Ovarian Cancer Microenvironmental Cells

Juan R. Cubillos‐Ruiz, Diana G. Martinez, Uciane K. Scarlett et al. · Oncotarget · 2010 · 72 citations · Full text